logo

For the Inventor, By the Inventor

Loveland, OH, United States of America

Laird F Miller

This inventor holds 7 USPTO granted patents. Top assignee: Richardson-Merrell Inc.. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laird F Miller. Retrieved from https://idiyas.com/inventor/laird-f-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal7 out of 167 
 
Richardson-Merrell Inc.
 patents

Years Active: 1976-1978

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4119775 - 4-Oxo-1-pyridinyl cephalosporin derivatives (1978-10-10),
2. 4108896 - Anthracene derivatives (1978-08-22),
3. 4008221 - 6-[(2,4-Dioxo-1-pyrimidinyl)acylamino]penicillin derivatives (1977-02-15),
4. 3994874 - 6-[(2-Oxo-1-pyridinyl)acylamino]penicillin derivatives (1976-11-30),
5. 3989687 - 4-Oxo-1-pyridinyl penicillin derivatives (1976-11-02),
6. 3956288 - 7-[(2,4-Dioxo-1-pyrimidinyl)acylamino]cephalosporin derivatives (1976-05-11),
7. 3956287 - 7-[(2-Oxo-1-pyridinyl)acylamino]cephalosporin derivatives (1976-05-11),

Title: The Innovative Contributions of Laird F. Miller

Introduction

Laird F. Miller, an accomplished inventor based in Loveland, Ohio, has made significant strides in the field of pharmaceutical innovations. With a total of seven patents to his name, Miller has continuously contributed to the development of novel antibacterial and antiviral agents, showcasing his commitment to advancing medical science.

Latest Patents

Miller's latest patents include groundbreaking work on 4-Oxo-1-pyridinyl cephalosporin derivatives, which are novel substituted compounds that serve as useful antibacterial agents. Additionally, he has developed anthracene derivatives, specifically 1,5 and 1,8-bis-basic ketones of anthracene, which show promise in the prevention and inhibition of viral infections. These innovative compounds are synthesized by reacting 1,5 and 1,8 bis(.omega.-haloacyl)anthracenes with a secondary amine, highlighting Miller's adeptness in medicinal chemistry.

Career Highlights

Throughout his career, Laird F. Miller has established himself as a valuable asset in the pharmaceutical industry. He is currently employed at Richardson-Merrell, Inc., where he collaborates on various research projects aimed at developing new therapeutic solutions. His extensive patent portfolio reflects his innovative thinking and dedication to solving pressing health challenges.

Collaborations

In his pursuit of advancing medical science, Miller has had the opportunity to work alongside notable colleagues such as Ronald E. Bambury and Michael L. Edwards. These collaborations have played a crucial role in the success of his projects, fostering an environment of creativity and shared expertise within the field.

Conclusion

Laird F. Miller's contributions to innovations in pharmaceuticals demonstrate the profound impact an inventor can have on global health. With his impressive array of patents and collaborations, he continues to pave the way for new medical treatments, showcasing the importance of inventors in the ongoing battle against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…